DNA Direct to Provide Personalized Reports for Iverson's Warfarin Sensitivity Test | GenomeWeb
NEW YORK (GenomeWeb News) - DNA Direct and Iverson Genetic Diagnostics said today that they are collaborating to provide personalized reports for customers of Iverson's warfarin-sensitivity assay.
 
Under the terms of the agreement, DNA Direct will provide a customized, web-based report for Iverson customers that will explain their test results in a “patient-friendly, interactive format,” the companies said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.